Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review.

Engin E, Treit D.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1399-419. doi: 10.1016/j.pnpbp.2008.03.020. Epub 2008 Apr 8. Review.

PMID:
18495312
2.

Effects of centrally administered anxiolytic compounds in animal models of anxiety.

Menard J, Treit D.

Neurosci Biobehav Rev. 1999 Mar;23(4):591-613. Review.

PMID:
10073896
3.

Role of the amygdala and periaqueductal gray in anxiety and panic.

Graeff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM.

Behav Brain Res. 1993 Dec 20;58(1-2):123-31. Review.

PMID:
8136040
4.

Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis.

de la Mora MP, Gallegos-Cari A, Arizmendi-García Y, Marcellino D, Fuxe K.

Prog Neurobiol. 2010 Feb 9;90(2):198-216. doi: 10.1016/j.pneurobio.2009.10.010. Epub 2009 Oct 21. Review.

PMID:
19853006
5.

Glutamate receptor ligands as anxiolytics.

Chojnacka-Wójcik E, Kłodzinska A, Pilc A.

Curr Opin Investig Drugs. 2001 Aug;2(8):1112-9. Review.

PMID:
11892923
6.

Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.

Atack JR.

Curr Drug Targets CNS Neurol Disord. 2003 Aug;2(4):213-32. Review.

PMID:
12871032
7.

Biological function of GABAA/benzodiazepine receptor heterogeneity.

Lüddens H, Korpi ER.

J Psychiatr Res. 1995 Mar-Apr;29(2):77-94. Review.

PMID:
7545236
8.

The role of hippocampus in anxiety: intracerebral infusion studies.

Engin E, Treit D.

Behav Pharmacol. 2007 Sep;18(5-6):365-74. Review.

PMID:
17762507
9.

Stress-induced vocalisation in adult animals. A valid model of anxiety?

Sánchez C.

Eur J Pharmacol. 2003 Feb 28;463(1-3):133-43. Review.

PMID:
12600706
10.

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.

Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Review.

PMID:
18761360
11.

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.

Palucha A, Pilc A.

Pharmacol Ther. 2007 Jul;115(1):116-47. Epub 2007 May 13. Review.

PMID:
17582504
12.

The use of cognitive enhancers in animal models of fear extinction.

Kaplan GB, Moore KA.

Pharmacol Biochem Behav. 2011 Aug;99(2):217-28. doi: 10.1016/j.pbb.2011.01.009. Epub 2011 Jan 20. Review.

PMID:
21256147
13.

Behavioral analogues of anxiety. Animal models.

Lal H, Emmett-Oglesby MW.

Neuropharmacology. 1983 Dec;22(12B):1423-41. Review.

PMID:
6142426
14.

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.

Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R.

Neurosci Biobehav Rev. 2002 May;26(3):259-83. Review.

PMID:
12034130
15.

Animal models of anxiety and anxiolytic drug action.

Treit D, Engin E, McEown K.

Curr Top Behav Neurosci. 2010;2:121-60. Review.

PMID:
21309109
16.

The role of GABA in the mediation and perception of pain.

Enna SJ, McCarson KE.

Adv Pharmacol. 2006;54:1-27. Review.

PMID:
17175808
17.

Role of CRF(1) and CRF(2) receptors in fear and anxiety.

Takahashi LK.

Neurosci Biobehav Rev. 2001 Dec;25(7-8):627-36. Review.

PMID:
11801288
18.

Serotonergic involvement in conflict behaviour.

Söderpalm B, Engel JA.

Eur Neuropsychopharmacol. 1990 Nov;1(1):7-13. Review.

PMID:
2136217
19.

The neurobiology and control of anxious states.

Millan MJ.

Prog Neurobiol. 2003 Jun;70(2):83-244. Review.

PMID:
12927745
20.

The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

Prut L, Belzung C.

Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33. Review.

PMID:
12600700

Supplemental Content

Support Center